194 related articles for article (PubMed ID: 22389180)
1. New pharmacological treatment strategies for relapse prevention.
Spanagel R; Vengeliene V
Curr Top Behav Neurosci; 2013; 13():583-609. PubMed ID: 22389180
[TBL] [Abstract][Full Text] [Related]
2. New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence.
Kiefer F; Mann K
Eur J Pharmacol; 2005 Dec; 526(1-3):163-71. PubMed ID: 16266700
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic approaches to the management of alcoholism.
Anton RF
J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical pharmacology of alcohol dependence.
Tambour S; Quertemont E
Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
[TBL] [Abstract][Full Text] [Related]
5. Treatment of alcohol dependence: recent progress and reduction of consumption.
Testino G; Leone S; Borro P
Minerva Med; 2014 Dec; 105(6):447-66. PubMed ID: 25392958
[TBL] [Abstract][Full Text] [Related]
6. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
7. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
Buri C; Moggi F; Giovanoli A; Strik W
Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
[TBL] [Abstract][Full Text] [Related]
8. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
[TBL] [Abstract][Full Text] [Related]
9. Emerging approaches to managing alcohol dependence.
Swift R
Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S12-22. PubMed ID: 17322178
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
11. Marketing Status and Perceived Efficacy of Drugs for Supporting Abstinence and Reducing Alcohol Intake in Alcohol Use Disorders: A Survey among European Federation of Addiction Societies in Europe.
Bramness JG; Mann K; Wurst FM
Eur Addict Res; 2016; 22(6):318-321. PubMed ID: 27438908
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention.
Jung YC; Namkoong K
Yonsei Med J; 2006 Apr; 47(2):167-78. PubMed ID: 16642544
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
Kiefer F; Helwig H; Tarnaske T; Otte C; Jahn H; Wiedemann K
Eur Addict Res; 2005; 11(2):83-91. PubMed ID: 15785069
[TBL] [Abstract][Full Text] [Related]
14. Medications for treating alcohol dependence.
Williams SH
Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1.
Kenna GA; McGeary JE; Swift RM
Am J Health Syst Pharm; 2004 Nov; 61(21):2272-9. PubMed ID: 15552634
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
Rösner S; Leucht S; Lehert P; Soyka M
J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological relapse prevention in alcohol and tobacco dependence].
Diehl A; Mann K
Internist (Berl); 2007 Jan; 48(1):79-84, 86-8. PubMed ID: 17122900
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of alcohol dependence: a review of the clinical data.
Mann K
CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
[TBL] [Abstract][Full Text] [Related]
19. Development of medications for alcohol use disorders: recent advances and ongoing challenges.
Litten RZ; Fertig J; Mattson M; Egli M
Expert Opin Emerg Drugs; 2005 May; 10(2):323-43. PubMed ID: 15934870
[TBL] [Abstract][Full Text] [Related]
20. Alcohol dependence and pharmacologic treatment. Introduction.
McDonough KP
Am J Health Syst Pharm; 2007 Mar; 64(5 Suppl 3):S3-4. PubMed ID: 17322180
[No Abstract] [Full Text] [Related]
[Next] [New Search]
